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Single shot “3-in-1” femoral nerve blockade with 0.25% or
0.375% levobupivacaine provides similar postoperative
analgesia for total knee replacement
Alpaslan APAN1, Filiz SARI2, Alp Burak EKMEKÇİ3

Aim: To compare postoperative analgesia provided by single shot “3-in-1” femoral nerve blockade using 0.25% or 0.375%
levobupivacaine in preceding with spinal anesthesia for unilateral total knee replacement surgery.
Materials and methods: Forty consenting patients undergoing unilateral total knee arthroplasty were included in this
prospective randomized study. Spinal anesthesia was achieved with 15 mg plain bupivacaine at the L3-4 or L4-5
interspace. After resolution of the spinal anesthesia, patients were randomized into 2 groups: “3-in-1” femoral nerve
blocks were performed using 30 mL of 0.25% levobupivacaine (Group 1, n = 20) or 0.375% levobupivacaine (Group 2,
n = 20). Pain was assessed by visual analogue scale (VAS). The total morphine consumption and the side effect profile
were compared during the postoperative period.
Results: There were no significant differences between the 2 study groups with respect to characteristics or intraoperative
variables. Furthermore, sensory block periods and time to first pain sensation, VAS, and morphine consumption for 24
h (Group 1: 19.7 ± 9.2, Group 2: 20.6 ± 12.1 mg) were similar. Pain scales and range of motion during rehabilitation
period and side effects were also comparable.
Conclusion: Our results indicate that the augmenting concentration did not influence the clinical outcome when single
shot “3-in-1” femoral nerve block was performed with 0.25% or 0.375% levobupivacaine in total knee arthroplasty.
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Postoperatif analjezide % 0,25 veya % 0,375 levobupivakain ile tek doz 3’e 1 femoral
sinir blokajı total diz protezi operasyonunda benzer analjezi sağlar
Amaç: Bu çalışmada tek taraflı total diz protezi cerrahisinde spinal anesteziyi takiben % 0,25 veya % 0,375 levobupivakain
kullanılarak yapılan 3 e 1 femoral sinir bloğunun etkinliğinin karşılaştırılması amaçlandı.
Yöntem ve gereç: Çalışmaya tek taraflı elektif diz cerrahisi geçirmesi planlanan onamı alınmış kırk hasta dahil edildi.
Spinal anestezi 15 mg düz bupivakain kullanılarak L3-4 veya L4-5 seviyesinden gerçekleştirildi. Spinal anestezinin ortadan
kalkmasından sonra hastalar randomize olarak iki gruba ayrıldı: 3 e 1 femoral blok 30 mL % 0,25 levobupivakain (Grup
1, n = 20) veya % 0,375 levobupivakain (Grup 2, n = 20) kullanılarak gerçekleştirildi. Ağrı Vizüel Analog Skala (VAS) ile
değerlendirildi. Postoperatif dönemde total morfin tüketimi ve yan etkiler belirlendi.
Bulgular: Her iki grup arasında hasta özellikleri veya intraoperatif değişimler açısından belirgin bir farklılık saptanmadı.
Bundan öte, duyu bloğu süresi, ilk ağrı duyumu, VAS ve ilk 24 saatlik morfin tüketimi (Grup 1: 19,7 ± 9,2, Grup 2: 20,6
± 12,1 mg) benzerdi. Ağrı skalaları, rehabilitasyon sırasındaki hareket genişliği ve yan etkiler benzerdi.
Sonuç: Bulgularımız % 0,25 veya % 0,375 levobupivakain kullanılarak yapılan tek doz 3 ü 1 yerde femoral sinir blokajında
konsantrasyon artışının klinik sonucu etkilemediğini gösterdi.
Anahtar sözcükler: Anestezi teknikleri, rejyonel, femoral sinir bloğu, ağrı, postoperatif, levobupivakain
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Introduction

Materials and methods

Pain is one of the major contributors to morbidity
in total knee replacement (TKR) surgery.
Postoperative pain is considered to be severe and
difficult to decrease with oral medications (1).
Postoperative analgesia may influence the outcome
including blood loss during this period (2), or quality
of life (3). It has also been demonstrated that epidural
analgesia may contribute to lower incidence of death
after surgery (4).

After obtaining approval from the local ethics
committee and written informed consent, 40
American Society of Anesthesiologists (ASA) class I
and II adult patients undergoing knee arthroplasty
were enrolled in the study. Exclusion criteria were
patient refusal, age < 18 years or > 85 years, body mass
2
index over 45 kg/m , infection at the injection site,
coagulation disorders or therapy, pre-existing
neurological disorder involving a lower extremity,
sepsis and any systemic illness that corresponds to
ASA class III or more. The study protocol,
randomization procedure, pain control, and
assessments were explained at least 1 day before the
operation during the preoperative visit. Patients were
randomly assigned into 2 groups using sealed
envelopes chosen before the operation.

Numerous methods are implicated to decrease
pain in the postoperative period. Peripheral nerve
blocks are widely accepted due to lower complication
rates, and they provide efficient long-term analgesia
during both for the operation and the postoperative
period. They also offer earlier ambulation with
shorter hospital stay (5,6). Femoral nerve block (FNB)
is associated with lower side effects when compared
with intravenous morphine and epidural analgesia
(7,8). It was also demonstrated that FNB, when added
to the epidural analgesia, significantly improved
analgesia for 2 days (9). Continuous FNB offers the
advantages of less nausea and vomiting but has higher
analgesic consumption than with continuous epidural
analgesia (10).
Although rare, serious complications might be
detected with peripheral nerve blocks due to the
requirement of high volume of local anesthetic
solutions. Cardiovascular complications might be
observed with accidental vascular entry during drug
disposition or rapid absorption from the injected site.
When compared to the racemic form, intravenous
levobupivacaine has been demonstrated to produce
significantly less effects on cardiovascular function
including negative inotropic effect in particular (11).
On the other hand, the optimal concentration of
levobupivacaine for FNB has never been determined
in patients undergoing total knee arthroplasty for
postoperative analgesia.
This study aimed to compare postoperative
analgesia of single shot “3-in-1” FNB using 0.25% or
0.375% levobupivacaine in combination with spinal
anesthesia for unilateral TKR surgery in order to
determine the optimal initial levobupivacaine
concentration for bolus dose.
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Patients were monitored with ECG and peripheral
O2 saturation continuously, and non-invasive arterial
blood pressure was determined and recorded every 5
min during the perioperative period and in the
recovery (Cardiocap 5 Datex-Ohmeda, Helsinki,
Finland). A large bore cannula was inserted to the
peripheral vein and pre-hydration with crystalloid
solution was started with a dose of 10 mL kg-1
administered within 15 min. Spinal anesthesia was
performed using 15 mg plain bupivacaine at L3-4 or L45 interspace with 25 gauge pencil-point needle (B.
Braun; Melsungen, Germany). After resolution of the
spinal anesthesia, which was assessed with pinpricks
during the recovery period, FNBs were performed for
postoperative analgesia.
The insertion point was classically determined as
1 to 1.5 cm lateral to the pulsation of the femoral
artery and just below the iliac crest using a short
beveled 5 cm long Stimuplex cannula (B. Braun;
Melsungen, Germany). Drug dilutions with labeled
syringes were prepared immediately before the
surgery in the Pharmacy Department. A peripheral
nerve stimulator was attached to the cannula with
settings at 2 Hz and pulse width of 0.1 s. While
contractions in the quadriceps femoris muscle were
still elucidated under 0.5 mAmp with a nerve
stimulator (HNS 11., B. Braun Melsungen, Germany),
30 mL of either 0.25% levobupivacaine (Group 1, n =
20), or 0.375% levobupivacaine (Group 2, n = 20) was
injected with increments and gentle aspirations. The
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success of the block was determined with pain
sensation using pinpricks at the distribution area of
all nerves and muscle strength according to ability to
raise the leg. Insufficient analgesia to the pinpricks or
no change in motor strength in the 30 min
observation period was accepted as failed block and
excluded from further analysis.
Pain was assessed with a standard plastic scale
according to the patient’s expression defined as Visual
Analogue Scale (VAS), from 0 = no pain to 100 =
worst imaginable pain determined at 4 h intervals on
the first postoperative day. Pain during passive
movements were also determined and assessed during
physiotherapy.
Patient-controlled analgesia (PCA) device
(Provider, Abbott, Chicago, USA) was attached to the
peripheral vein with a stopcock and set at 1 mg
morphine with 5-min lockout interval. Total
morphine consumption and the side effect profile
were compared for 48 h and assessed every 4 h.
Analgesia in the postoperative period was provided
with a PCA device. Analgesic requirements, time to
first analgesic, and sum of the analgesics were
recorded for both study groups. Time to first analgesic
was determined as first analgesic requirement with
PCA from 3-in-1 block noted by the patient or
relatives. Analgesia and analgesic requirements were
assessed every 4 h.

Our preliminary study and power analysis failed
to determine any difference in morphine
consumption and pain scale during the postoperative
period. We, therefore, limited the number of subjects
to 20 patients in each group. Demographic data were
compared with X2 test. Nominal data, such as
morphine consumption, were evaluated with one-way
analysis of variance (ANOVA), and paired-t tests were
used for statistical comparison. Ordinal data
including pain scores were determined using MannWhitney U tests. Data were expressed as mean ± SD
and P value was considered as 0.05 for statistical
significance.
Results
Demographic characteristics of the study groups
were the same, and there was no statistically
significant difference (P > 0.05). Moreover, tourniquet
times, duration of surgery, time in recovery, and
length of hospital stay were all similar (P > 0.05, Table
1).
Vital signs were stable throughout the operation
and no medication was required. Analgesia was
obtained from the distribution area of the nerves in
all patients.
Times to first pain and rescue analgesic were
similar between the study groups. There was also no

Table 1. Patients’ characteristics, surgical data, and length of stay, (mean ±SD).
Group 1
(n = 20)

Group 2
(n = 20)

P

Age (year)

65.7 ± 8.1

62.0 ± 5.7

0.12

Weight (kg)

76.4 ± 11.0

81.1 ± 14.5

0.28

Height (cm)

159.3 ± 4.7

156.3 ± 6.7

0.19

Gender (F/M)

18 / 2

18 / 2

1.0

ASA class (I/II)

6 / 14

4 / 16

0.71

Tourniquet time (min)

63.7 ± 13.8

65.9 ± 16.3

0.18

Duration of surgery (min)

89.3 ± 10.9

83.7 ± 19.1

0.20

Time in recovery (min)

78.6 ± 25.3

81.4 ± 28.9

0.26

3.9 ± 2.1

3.6 ± 2.4

0.61

Length of stay (days)

ASA: American Society of Anesthesiology.
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significant
difference
between
morphine
consumption after 12, 24, and 48 h periods (Table 2.).
Pain scales during postoperative were comparable and
no significant difference was determined during the
observation period (Figure 1). No statistically
significant difference between pain scores assessed
with VAS during passive movement at the 6 h, 12 h, 24
h and 48 h time points (Figure 2).
Side effects in the postoperative period were
similar (P > 0.05). Mild nausea was observed in 3
patients in Group 1 and 4 patients in Group 2, which
did not require medication. Mild itching was seen in
2 patients in Group 1 and 1 patient in Group 2, and
also subsided without treatment.
No patients had residual numbness, dysesthesia,
or weakness associated with spinal anesthesia or FNB.

Discussion
In the present study, there was no significant
difference between postoperative pain scores with 3in-1 femoral nerve block using 0.25% or 0.375%
levobupivacaine after TKR surgery. Morphine
consumption, functional outcome and side effect
profile between the study groups were also
comparable. The possible outcome of our results is
more important in the patients with comorbidities by
limiting the dose requirements.
Ng et al. (12) demonstrated that there were no
significant differences in postoperative pain scales and
analgesic consumptions between 0.25% and 0.5%
ropivacaine with 0.25% bupivacaine during
intraoperative single shot 3-in-1 FNB in TKR surgery.
According to the current literature, there is no study

Table 2. Time to first pain, analgesic and morphine consumption in the postoperative
period (mean ±SD).
Group 1
(n = 20)

Group 2
(n = 20)

P

Time to first pain (min)

322.3 ± 126.7

296.2 ± 69.6

0.23

Time to first analgesic (min)

349.7 ± 142.9

338.3 ± 56.1

0.54

12 h

6.9 ± 4.7

6.4 ± 5.6

0.49

24 h

19.7 ± 9.2

20.6 ± 12.1

0.57

48 h

29.9 ± 13.4

31.3 ± 16.8

0.31

Morphine consumption (mg)

45
40
35
30
25
20
15
10
5
0

60

Group I
Group II

(0.73)

(0.92)

(0.69)
(0.18)

(0.10)
0

4

8
Time (hour)

12

24

Figure 1. Postoperative pain during rest assessed with visual
analogue scale, (p).
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VAS in movement (mm)

Visual Analogue Scale (mm)

70
Group I
Group II

(0.44)
(0.30)

50
40

(0.14)
(0.26)

30
20
10
0

6

12

24
Time (hour)

48

Figure 2. Visual analogue scale (VAS) in passive movement, (p).
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comparing the different concentrations of
levobupivacaine for postoperative analgesia using the
same surgical model. Levobupivacaine has been
largely accepted as a safe drug when compared to the
racemic form. However, the potential of dose- and
concentration-dependent
nerve
injury
or
myonecrosis has been implicated (13). Therefore,
increasing the concentration is not recommended due
to limited efficacy and to prevent potential
complications.
When compared to the central neuroaxial
blocks, contraindications of peripheral nerve blocks
are rare due to lacks of hemodynamic side effects.
The incidence of complication rate has also been
found to be lower than general anesthesia and
neuroaxial blocks. There is a tendency to use
peripheral nerve blocks especially for postoperative
analgesia in TKR (14). In addition to its simplicity
and safety, 3-in-1 FNB has been demonstrated to be
as efficient as posterior compartment (psoas) block
in total knee arthroplasty (15), without possible
nerve injury (16). Although the mean pain scores
during rest and physical therapy and opioid
consumptions were lower with continuous FNB
when compared with single injection, there was no
change in the outcome of hospital stay (17). It has
also been demonstrated that a single injection of
FNB provides equivalent analgesia with a reduction
in side effects when compared with intrathecal
morphine administration (18). We also recommend
this safe technique using levobupivacaine in order
to decrease morphine consumption at lower
concentration. The combination of regional
techniques and parenteral drugs with potentially
fewer side effects might be an optional solution for
pain therapy in TKR surgery (1).

Femoral and sciatic catheter is superior to femoral
and psoas catheter with respect to reduced analgesic
requirements; however, functional outcomes did not
differ from those with continuous regional analgesia
techniques (19). When compared with the FNB alone,
combination of continuous femoral and sciatic nerve
blocks improves analgesia while decreasing morphine
consumption and postoperative nausea or vomiting
(20,21). Macalou et al. (22) also indicated that
obturator nerve block when added to the 3-in-1 FNB
provides better analgesia. However, addition of any
technique results in a risk of complications and
possible confusion during the pain assessment. On
the other hand, our results might be useful with
limiting the total local anesthetic dose when
combination of peripheral nerve block is required.
Levobupivacaine might reach the toxic level when the
combination of posterior lumbar plexus and sciatic
nerve blocks are used for TKR. Authors also
emphasize the difference between absorption of local
anesthetics according to the region due to the
vascularity (23).
Our results indicate that increasing the
levobupivacaine concentration was not effective in 3in-1 FNB possibly due to the vascular supply of the
region. It might be helpful to decrease the local
anesthetic dose during combination of peripheral
nerve blocks and therefore possible toxicity or
complications.
Conclusion
Our results indicate that the augmenting
concentration did not influence the clinical outcome
when single shot “3-in-1” FNB was performed with
0.25% or 0.375% levobupivacaine in TKR.
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